Women's Health Research Roundup for Primary Care: Key Studies At-a-Glance from TMS 2025

The Menopause Society 2025 Annual Meeting delivered a breadth of new research with direct implications for primary care practice, from updates on menopausal hormone therapy (MHT) and emerging nonhormonal treatments to real-world data on sleep, vasomotor symptoms, cognition, cardiovascular risk, and ongoing disparities in access to menopause care. In the slides above, find details from 7 key studies presented at the meeting, including evidence on age-related brain changes, the potential “critical window” for MHT, performance of agents such as fezolinetant and elinzanetant, safety data on investigational estrogen therapies, and new insights into gaps in training and treatment equity.